News

Coronavirus (COVID-19) Update: October 22, 2021

The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: Today, the FDA began…

FDA In Brief: FDA Announces Investigation of Salmonella Outbreak Linked to Whole, Fresh Onions

The following quote is attributed to Frank Yiannas, FDA Deputy Commissioner for Food Policy and Response Español “The FDA, along with the CDC and our…

Coronavirus (COVID-19) Update: FDA Takes Additional Actions on the Use of a Booster Dose for COVID-19 Vaccines

Today, the U.S. Food and Drug Administration took action to expand the use of a booster dose for COVID-19 vaccines in eligible populations. The agency…

Federal Judge Enters Consent Decree with Utah-based Dietary Supplement Manufacturer

A dietary supplement manufacturer and its two owners have been ordered by a federal court to stop selling products until they come into compliance with…

Coronavirus (COVID-19) Update: October 19, 2021

The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: On Oct. 12, the…

FDA Issues Landmark Proposal to Improve Access to Hearing Aid Technology for Millions of Americans

Today, the U.S. Food and Drug Administration issued a landmark proposal intended to improve access to and reduce the cost of hearing aid technology for…

FDA Permits Marketing of New Oral Tobacco Products through Premarket Tobacco Product Application Pathway

Today, the U.S. Food and Drug Administration announced it has authorized the marketing of four new oral tobacco products manufactured by U.S. Smokeless Tobacco Company…

FDA Approves Cyltezo, the First Interchangeable Biosimilar to Humira

The U.S. Food and Drug Administration approved the first interchangeable biosimilar product to treat certain inflammatory diseases. Cyltezo (adalimumab-adbm), originally approved in August 2017, is…

Coronavirus (COVID-19) Update: 10/15/21

The U.S. Food and Drug Administration (FDA) continued to take action in the ongoing response to the COVID-19 pandemic: On Oct. 12, the FDA posted…

FDA Awards 11 Grants to Clinical Trials to Develop New Medical Products for Rare Disease Treatments

Today, the U.S. Food and Drug Administration announced it has awarded 11 new clinical trial research grants, equaling more than $25 million of funding over…